Preserving Beta Cell Function in T1D: Current Strategies and Emerging Therapies
A panelist discusses how preserving beta-cell function in type 1 diabetes (T1D) requires a multifaceted approach combining timely diagnosis, immunomodulatory therapies, optimal glycemic control and emerging technologies that can slow disease progression and improve patient outcomes.
Video content above is prompted by the following:
- What current strategies or therapies are being utilized to preserve beta cell function in patients with T1D?
- What pharmacologic and nonpharmacologic strategies are recommended by the American Diabetes Association to prevent the progression of early-stage T1D to clinical-stage 3 T1D?
- What are the most common challenges health care providers face when managing patients’ T1D?
- What opportunities are available for overcoming these challenges?
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Recent Videos
Related Content
